Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnosis of Schizophrenia and its Subtypes Using MRI and Machine Learning

Hosna Tavakoli, Reza Rostami, Reza Shalbaf, Mohammad-Reza Nazem-Zadeh
doi: https://doi.org/10.1101/2024.08.09.24311726
Hosna Tavakoli
1Computational and Artificial Intelligence Department, Institute of Cognitive Science Studies, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reza Rostami
1Computational and Artificial Intelligence Department, Institute of Cognitive Science Studies, Tehran, Iran
3Department of Psychology, Tehran University, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reza Shalbaf
1Computational and Artificial Intelligence Department, Institute of Cognitive Science Studies, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad-Reza Nazem-Zadeh
1Computational and Artificial Intelligence Department, Institute of Cognitive Science Studies, Tehran, Iran
2Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
4Department of Neuroscience, Monash University, Melbourne, VIC, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mohamad.nazem-zadeh{at}monash.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose The neurobiological heterogeneity present in schizophrenia remains poorly understood. This likely contributes to the limited success of existing treatments and the observed variability in treatment responses. Our objective was to employ magnetic resonance imaging (MRI) and machine learning (ML) algorithms to improve the classification of schizophrenia and its subtypes.

Method We utilized a public dataset provided by the UCLA Consortium for Neuropsychiatric Research, containing structural MRI and resting-state fMRI (rsfMRI) data. We integrated all individuals within the dataset diagnosed with schizophrenia (N=50); along with age- and gender-matched healthy individuals (N=50). We extracted volumetrics of 66 subcortical and thickness of 72 cortical regions. Additionally, we obtained four graph-based measures for 116 intracranial regions from rsfMRI data including degree, betweenness centrality, participation coefficient, and local efficiency. Employing conventional ML methods, we sought to distinguish the patients with schizophrenia from healthy individuals. Furthermore, we applied the methods for discriminating subtypes of schizophrenia. To streamline the feature set, various feature selection techniques were applied. Furthermore, a validation phase involved employing the model on a dataset domestically acquired using the same imaging assessments (N=13). Finally, we explored the correlation between neuroimaging features and behavioral assessments.

Finding The classification accuracy reached as high as 79% in distinguishing schizophrenia patients from healthy in the UCLA dataset. This result was achieved by the k-nearest neighbor algorithm, utilizing 12 brain neuroimaging features, selected by the feature selection method of Minimum Redundancy Maximum Relevance (MRMR). The model demonstrated high effectiveness (85% accuracy) in estimating the disease vs. control label for a new dataset acquired domestically. Using a linear SVM on 62 features obtained from MRMR, patients with schizophrenic subtypes were classified with an accuracy of 64%. The highest spearman correlation coefficient between the neuroimaging features and behavioral assessments was observed between degree of the postcentral gyrus and mean reaction time in the verbal capacity task (r = 0.49, p = 0.001).

Conclusion The findings of this study underscore the utility of MRI and ML algorithms in enhancing the diagnostic process for schizophrenia. Furthermore, these methods hold promise for detecting both brain-related abnormalities and cognitive impairments associated with this disorder.

Highlights

  • The neurobiological heterogeneity present in schizophrenia remains poorly understood.

  • This likely contributes to the limited success of existing treatments and the observed variability in treatment responses.

  • Magnetic resonance imaging (MRI) and machine learning (ML) algorithms can improve the classification of schizophrenia and its subtypes.

  • Structural and functional measures of MRI can discriminate Schizophrenia form healthy individuals with almost 80% accuracy.

  • Paranoid is the most distinguishable subtype of schizophrenia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Strategic Technologies Development of National Elite Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants provided informed consent according to the study protocol approved by the ethics committee of research, Iran University of Medical Sciences.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 09, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosis of Schizophrenia and its Subtypes Using MRI and Machine Learning
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnosis of Schizophrenia and its Subtypes Using MRI and Machine Learning
Hosna Tavakoli, Reza Rostami, Reza Shalbaf, Mohammad-Reza Nazem-Zadeh
medRxiv 2024.08.09.24311726; doi: https://doi.org/10.1101/2024.08.09.24311726
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Diagnosis of Schizophrenia and its Subtypes Using MRI and Machine Learning
Hosna Tavakoli, Reza Rostami, Reza Shalbaf, Mohammad-Reza Nazem-Zadeh
medRxiv 2024.08.09.24311726; doi: https://doi.org/10.1101/2024.08.09.24311726

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)